The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Immunoregulatory functions of mTOR inhibition
Open accessAbstract
The potent immunosuppressive action of rapamycin is commonly ascribed to inhibition of growth factor-induced T cell proliferation. However, it is now evident that the serine/threonine protein kinase mammalian target of rapamycin (mTOR) has an important role in the modulation of both innate and adaptive immune responses. mTOR regulates diverse functions of professional antigen-presenting cells, such as dendritic cells (DCs), and has important roles in the activation of effector T cells and the function and proliferation of regulatory T cells. In this Review, we discuss our current understanding of the mTOR pathway and the consequences of mTOR inhibition, both in DCs and T cells, including new data on the regulation of forkhead box P3 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Vera, L. M., Oliveira, C. D., Olmeda, J. F. L., Ramos, J., Mañanós, E. L., Madrid, J. A., & Vázquez, F. J. S. (2007) · Hispana · doi:10.1111/j.1600 · Cited by 1,957
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,560
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,415
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast
Noda, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3963 · Cited by 1,309
Eisen, H. J., Tuzcu, E. M., Dorent, R., Kobashigawa, J., Mancini, D., Valantine-von Kaeppler, H. A., Starling, R. C., Sørensen, K., Hummel, M., Lind, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022171 · Cited by 1,198
Tor-Mediated Induction of Autophagy via an Apg1 Protein Kinase Complex
Kamada, Y., Funakoshi, T., Shintani, T., Nagano, K., Ohsumi, M., & Ohsumi, Y. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1507 · Cited by 1,145
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
Battaglia, M., Stabilini, A., & Roncarolo, M.-G. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,134
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Kim, D.-H., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K. V. P., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 961
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight, Z. A., Cobb, B. S., Cantrell, D., O'Connor, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800928105 · Cited by 865
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Tone, Y., Furuuchi, K., Kojima, Y., Tykocinski, M. L., Greene, M. I., & Tone, M. (2008) · Nature Immunology · doi:10.1038/ni1549 · Cited by 807
Sun, S.-Y., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., & Khuri, F. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0917 · Cited by 802
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.012 · Cited by 801
Sirolimus: its discovery, biological properties, and mechanism of action
Sehgal, S. N. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00211-2 · Cited by 779
Li, Y., Li, X. C., Zheng, X. X., Wells, A. D., Turka, L. A., & Strom, T. B. (1999) · Nature Medicine · doi:10.1038/15256 · Cited by 745
The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
Foxp3 in control of the regulatory T cell lineage
Zheng, Y., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1455 · Cited by 701
mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s
Frias, M. A., Thoreen, C. C., Jaffe, J. D., Schroder, W., Sculley, T., Carr, S. A., & Sabatini, D. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.001 · Cited by 695
A Two-Step Process for Thymic Regulatory T Cell Development
Lio, C.-W. J., & Hsieh, C.-S. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.021 · Cited by 661
The known unknowns of antigen processing and presentation
Vyas, J. M., Van der Veen, A. G., & Ploegh, H. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2368 · Cited by 653
mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes
Hresko, R. C., & Mueckler, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508361200 · Cited by 635
WNT signalling in the immune system: WNT is spreading its wings
Staal, F. J. T., Luis, T. C., & Tiemessen, M. M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2360 · Cited by 582
Schmid, D., Pypaert, M., & Münz, C. (2007) · Immunity · doi:10.1016/j.immuni.2006.10.018 · Cited by 577
Yang, Q., & Guan, K.-L. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 535
PI3K-mediated negative feedback regulation of IL-12 production in DCs
Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., & Koyasu, S. (2002) · Nature Immunology · doi:10.1038/ni825 · Cited by 529
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Roncarolo, M.-G., & Battaglia, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2138 · Cited by 515
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Zeiser, R., Nguyen, V. H., Beilhack, A., Buess, M., Schulz, S., Baker, J., Contag, C. H., & Negrin, R. S. (2006) · Blood · doi:10.1182/blood-2006-01-0329 · Cited by 504
Jagannath, C., Lindsey, D. R., Dhandayuthapani, S., Xu, Y., Hunter, R. L., & Eissa, N. T. (2009) · Nature Medicine · doi:10.1038/nm.1928 · Cited by 494
Brint, E. K., Xu, D., Liu, H., Dunne, A., McKenzie, A. N. J., O'Neill, L. A. J., & Liew, F. Y. (2004) · Nature Immunology · doi:10.1038/ni1050 · Cited by 489
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9508-9516.2004 · Cited by 485
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Rapamycin in transplantation: A review of the evidence
Saunders, R. N., Metcalfe, M. S., & Nicholson, M. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00460.x · Cited by 461
Turnquist, H. R., Raimondi, G., Zahorchak, A. F., Fischer, R. T., Wang, Z., & Thomson, A. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7018 · Cited by 441
Self-citationBurchill, M. A., Yang, J., Vang, K. B., Moon, J. J., Chu, H. H., Lio, C.-W. J., Vegoe, A. L., Hsieh, C.-S., Jenkins, M. K., & Farrar, M. A. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.022 · Cited by 418
Zeiser, R., Leveson-Gower, D. B., Zambricki, E. A., Kambham, N., Beilhack, A., Loh, J., Hou, J.-Z., & Negrin, R. S. (2008) · Blood · doi:10.1182/blood-2007-06-094482 · Cited by 402
Cao, W., Manicassamy, S., Tang, H., Kasturi, S. P., Pirani, A., Murthy, N., & Pulendran, B. (2008) · Nature Immunology · doi:10.1038/ni.1645 · Cited by 398
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
Sinclair, L. V., Finlay, D., Feijoo, C., Cornish, G. H., Gray, A., Ager, A., Okkenhaug, K., Hagenbeek, T. J., Spits, H., & Cantrell, D. A. (2008) · Nature Immunology · doi:10.1038/ni.1603 · Cited by 390
Hackstein, H., Taner, T., Zahorchak, A. F., Morelli, A. E., Logar, A. J., Gessner, A., & Thomson, A. W. (2003) · Blood · doi:10.1182/blood-2002-11-3370 · Cited by 381
Self-citationRapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Zeng, Z., Sarbassov, D. D., Samudio, I. J., Yee, K. W. L., Munsell, M. F., Ellen Jackson, C., Giles, F. J., Sabatini, D. M., Andreeff, M., & Konopleva, M. (2007) · Blood · doi:10.1182/blood-2006-06-030833 · Cited by 342
Strauss, L., Whiteside, T. L., Knights, A., Bergmann, C., Knuth, A., & Zippelius, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.320 · Cited by 336
Reversal of in vitro T cell clonal anergy by IL-2 stimulation
Beverly, B., Kang, S.-M., Lenardo, M. J., & Schwartz, R. H. (1992) · International Immunology · doi:10.1093/intimm/4.6.661 · Cited by 333
Translational control of the innate immune response through IRF-7
Colina, R., Costa-Mattioli, M., Dowling, R. J. O., Jaramillo, M., Tai, L.-H., Breitbach, C. J., Martineau, Y., Larsson, O., Rong, L., Svitkin, Y. V., et al. (2008) · Nature · doi:10.1038/nature06730 · Cited by 316
IL-15 and IL-2: a matter of life and death for T cells in vivo
Li, X. C., Demirci, G., Ferrari-Lacraz, S., Groves, C., Coyle, A., Malek, T. R., & Strom, T. B. (2001) · Nature Medicine · doi:10.1038/83253 · Cited by 312
Prevention of T Cell Anergy by Signaling Through the γ c Chain of the IL-2 Receptor
Boussiotis, V. A., Barber, D. L., Nakarai, T., Freeman, G. J., Gribben, J. G., Bernstein, G. M., D'Andrea, A. D., Ritz, J., & Nadler, L. M. (1994) · Science · doi:10.1126/science.7973657 · Cited by 307
Ohtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., Takeuchi, T., Matsuda, S., & Koyasu, S. (2008) · Blood · doi:10.1182/blood-2008-02-137430 · Cited by 265
Gao, W., Lu, Y., El Essawy, B., Oukka, M., Kuchroo, V. K., & Strom, T. B. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01842.x · Cited by 260
Coenen, J. J. A., Koenen, H. J. P. M., van Rijssen, E., Hilbrands, L. B., & Joosten, I. (2006) · Blood · doi:10.1182/blood-2005-07-3032 · Cited by 252
Segundo, D. S., Ruiz, J. C., Izquierdo, M., Fernández-Fresnedo, G., Gómez-Alamillo, C., Merino, R., Benito, M. J., Cacho, E., Rodrigo, E., Palomar, R., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000229473.95202.50 · Cited by 249
Taner, T., Hackstein, H., Wang, Z., Morelli, A. E., & Thomson, A. W. (2005) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2004.00673.x · Cited by 249
Self-citationUse of Sirolimus in Solid Organ Transplantation
Augustine, J. J., Bodziak, K. A., & Hricik, D. E. (2007) · Drugs · doi:10.2165/00003495-200767030-00004 · Cited by 247
Crellin, N. K., Garcia, R. V., & Levings, M. K. (2007) · Blood · doi:10.1182/blood-2006-07-035279 · Cited by 234
Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs
Noris, M., Casiraghi, F., Todeschini, M., Cravedi, P., Cugini, D., Monteferrante, G., Aiello, S., Cassis, L., Gotti, E., Gaspari, F., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101143 · Cited by 230
Koehl, G. E., Andrassy, J., Guba, M., Richter, S., Kroemer, A., Scherer, M. N., Steinbauer, M., Graeb, C., Schlitt, H. J., Jauch, K.-W., et al. (2004) · Transplantation · doi:10.1097/00007890-200405150-00002 · Cited by 222
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Schmitz, F., Heit, A., Dreher, S., Eisenächer, K., Mages, J., Haas, T., Krug, A., Janssen, K., Kirschning, C. J., & Wagner, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838761 · Cited by 212
Drug eluting stents: an updated meta-analysis of randomised controlled trials
Roiron, C., Sanchez, P., Bouzamondo, A., Lechat, P., & Montalescot, G. (2006) · Heart · doi:10.1136/hrt.2005.061622 · Cited by 210
Greene, M. W., Sakaue, H., Wang, L., Alessi, D. R., & Roth, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209153200 · Cited by 201
Passerini, L., Allan, S. E., Battaglia, M., Di Nunzio, S., Alstad, A. N., Levings, M. K., Roncarolo, M. G., & Bacchetta, R. (2008) · International Immunology · doi:10.1093/intimm/dxn002 · Cited by 200
Interleukin-2 receptor signaling in regulatory T cell development and homeostasis
Burchill, M. A., Yang, J., Vang, K. B., & Farrar, M. A. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.08.005 · Cited by 199
Valmori, D., Tosello, V., Souleimanian, N. E., Godefroy, E., Scotto, L., Wang, Y., & Ayyoub, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.944 · Cited by 196
Cutler, C., Li, S., Ho, V. T., Koreth, J., Alyea, E., Soiffer, R. J., & Antin, J. H. (2007) · Blood · doi:10.1182/blood-2006-09-046219 · Cited by 187
Transient aggregation of ubiquitinated proteins during dendritic cell maturation
Lelouard, H., Gatti, E., Cappello, F., Gresser, O., Camosseto, V., & Pierre, P. (2002) · Nature · doi:10.1038/417177a · Cited by 187
Novel roles of Akt and mTOR in suppressing TGF‐β/ALK5‐mediated Smad3 activation
Song, K., Wang, H., Krebs, T. L., & Danielpour, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600917 · Cited by 185
The Pim kinases control rapamycin-resistant T cell survival and activation
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042020 · Cited by 185
Basu, S., Golovina, T., Mikheeva, T., June, C. H., & Riley, J. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5794 · Cited by 183
Battaglia, M., Stabilini, A., Draghici, E., Gregori, S., Mocchetti, C., Bonifacio, E. E., & Roncarolo, M. (2006) · PubMed · Cited by 176
Tremblay, F., Gagnon, A., Veilleux, A., Sorisky, A., & Marette, A. (2005) · Endocrinology · doi:10.1210/en.2004-0777 · Cited by 175
Blaha, P., Bigenzahn, S., Koporc, Z., Schmid, M., Langer, F., Selzer, E., Bergmeister, H., Wrba, F., Kurtz, J., Kiss, C., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3014 · Cited by 175
Battaglia, M., Stabilini, A., Draghici, E., Gregori, S., Mocchetti, C., Bonifacio, E., & Roncarolo, M.-G. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0613 · Cited by 174
Hackstein, H., Taner, T., Logar, A. J., & Thomson, A. W. (2002) · Blood · doi:10.1182/blood.v100.3.1084 · Cited by 173
Self-citationRapamycin impairs antigen uptake of human dendritic cells1
Monti, P., Mercalli, A., Leone, B. E., Valerio, D. C., Allavena, P., & Piemonti, L. (2003) · Transplantation · doi:10.1097/00007890-200301150-00025 · Cited by 165
PTEN inhibits IL-2 receptor-mediated expansion of CD4+CD25+ Tregs
Walsh, P. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28057 · Cited by 164
Coenen, J. J. A., Koenen, H. J. P. M., van Rijssen, E., Kasran, A., Boon, L., Hilbrands, L. B., & Joosten, I. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705628 · Cited by 164
Colombetti, S., Basso, V., Mueller, D. L., & Mondino, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2730 · Cited by 159
Woltman, A. M., de Fijter, J. W., Kamerling, S. W. A., van der Kooij, S. W., Paul, L., Daha, M. R., & van Kooten, C. (2001) · Blood · doi:10.1182/blood.v98.1.174 · Cited by 159
Battaglia, M., Stabilini, A., Draghici, E., Migliavacca, B., Gregori, S., Bonifacio, E. E., & Roncarolo, M. (2006) · Diabetes · doi:10.2337/db05-1576 · Cited by 156
Woltman, A. M., van der Kooij, S. W., Coffer, P. J., Offringa, R., Daha, M. R., & van Kooten, C. (2003) · Blood · doi:10.1182/blood-2002-06-1688 · Cited by 153
Antin, J. H., Kim, H. T., Cutler, C. S., Ho, V. T., Lee, S. J., Miklos, D. B., Hochberg, E. P., Wu, C. J., Alyea, E. P., & Soiffer, R. J. (2003) · Blood · doi:10.1182/blood-2003-02-0489 · Cited by 153
Astrinidis, A., Cash, T. P., Hunter, D., Walker, C. L., Chernoff, J., & Henske, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205962 · Cited by 153
Use of sirolimus (rapamycin) to treat refractory Crohn’s disease
Massey, D. C. O., Bredin, F., & Parkes, M. (2008) · Gut · doi:10.1136/gut.2008.157297 · Cited by 151
Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells
Monti, P., Scirpoli, M., Maffi, P., Piemonti, L., Secchi, A., Bonifacio, E. E., Roncarolo, M., & Battaglia, M. (2008) · Diabetes · doi:10.2337/db08-0138 · Cited by 143
LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway
Chen, E. J., & Kaiser, C. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200210141 · Cited by 139
Matsue, H., Yang, C., Matsue, K., Edelbaum, D., Mummert, M. E., & Takashima, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3555 · Cited by 138
COMBINED COSTIMULATION BLOCKADE PLUS RAPAMYCIN BUT NOT CYCLOSPORINE PRODUCES PERMANENT ENGRAFTMENT1
Li, Y., Zheng, X. X., Li, X. C., Zand, M. S., & Strom, T. B. (1998) · Transplantation · doi:10.1097/00007890-199811270-00021 · Cited by 134
Dames, S. A., Mulet, J. M., Rathgeb–Szabo, K., Hall, M. N., & Grzesiek, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501116200 · Cited by 134
Regulation of Glycogen Synthesis by Amino Acids in Cultured Human Muscle Cells
Armstrong, J. L., Bonavaud, S. M., Toole, B. J., & Yeaman, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004812200 · Cited by 133
Inhibition of Human B Lymphocyte Cell Cycle Progression and Differentiation by Rapamycin
Aagaard-Tillery, K. M., & Jelinek, D. F. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1193 · Cited by 126
The kinases aurora B and mTOR regulate the G1–S cell cycle progression of T lymphocytes
Song, J. J., Salek‐Ardakani, S., So, T., & Croft, M. (2006) · Nature Immunology · doi:10.1038/ni1413 · Cited by 120
Heidt, S., Roelen, D. L., Eijsink, C., van Kooten, C., Claas, F. H. J., & Mulder, A. (2008) · Transplantation · doi:10.1097/tp.0b013e3181874a36 · Cited by 119
Lorne, E., Zhao, X., Zmijewski, J. W., Liu, G., Park, Y.-J., Tsuruta, Y., & Abraham, E. H. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0290oc · Cited by 118
Lee, Y.-R., Yang, I.-H., Lee, Y., Im, S., Song, S., Li, H., Han, K., Kim, K., Eo, S. K., & Lee, C. (2005) · Blood · doi:10.1182/blood-2004-10-3927 · Cited by 116
Weinstein, S. L., Finn, A. J., Davé, S. H., Meng, F., Lowell, C. A., Sanghera, J. S., & DeFranco, A. L. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.3.405 · Cited by 114
Armand, P. A., Gannamaneni, S., Kim, H. T., Cutler, C. S., Ho, V. T., Koreth, J., Alyea, E. P., LaCasce, A. S., Jacobsen, E. D., Fisher, D. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7279 · Cited by 114
Use of Sirolimus in IPEX and IPEX-Like Children
Yong, P. L., Russo, P., & Sullivan, K. E. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9196-1 · Cited by 108
mTOR at the crossroads of T cell proliferation and tolerance
Mondino, A., & Mueller, D. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.008 · Cited by 108
Yang, C., Song, C., Lee, J., Jung, S.-B., Oh, J.-H., Park, J., Kim, H., Park, J., Paik, T.-H., & Jo, E. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00699.x · Cited by 107
Lymphoid Sequestration of Alloreactive Memory CD4 T Cells Promotes Cardiac Allograft Survival
Zhang, Q., Chen, Y.-F., Fairchild, R. L., Heeger, P. S., & Valujskikh, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.770 · Cited by 105
Ueno, T., Habicht, A., Clarkson, M. R., Albin, M. J., Yamaura, K., Boenisch, O., Popoola, J., Wang, Y., Yagita∥, H., Akiba, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32451 · Cited by 105
Donahue, A. C., & Fruman, D. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5851 · Cited by 101
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
Wai, L., Fujiki, M., Takeda, S., Martinez, O., & Krams, S. (2008) · Transplantation · doi:10.1097/01.tp.0000296817.28053.7b · Cited by 97
Rapamycin inhibits GM‐CSF‐induced neutrophil migration
Gómez-Cambronero, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00828-7 · Cited by 97
Delivery of rapamycin to dendritic cells using degradable microparticles
Jhunjhunwala, S., Raimondi, G., Thomson, A. W., & Little, S. R. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.011 · Cited by 96
Self-citationMaking regulatory T cells with defined antigen specificity: role in autoimmunity and cancer
Kretschmer, K., Apostolou, I., Jaeckel, E., Khazaie, K., & von Boehmer, H. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00411.x · Cited by 95
Hickman, S. P., Yang, J., Thomas, R. M., Wells, A. D., & Turka, L. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2186 · Cited by 91
Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells
Haddadi, A., Elamanchili, P., Lavasanifar, A., Das, S., Shapiro, J., & Samuel, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31373 · Cited by 90
Reichardt, W., Dürr, C., von Elverfeldt, D., Jüttner, E., Gerlach, U. V., Yamada, M., Smith, B., Negrin, R. S., & Zeiser, R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4770 · Cited by 88
Donahue, A. C., & Fruman, D. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737281 · Cited by 85
Hypoxia stimulus: An adaptive immune response during dendritic cell maturation
Rama, I., Brüne, B., Torrás, J., Koehl, R., Cruzado, J. M., Bestard, O., Franquesa, M., Lloberas, N., Weigert, A., Herrero, I., et al. (2008) · Kidney International · doi:10.1038/sj.ki.5002792 · Cited by 80
Zeiser, R., & Negrin, R. S. (2008) · Cell Cycle · doi:10.4161/cc.7.4.5454 · Cited by 79
Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice
Lui, S. L., Tsang, R. W. C., Chan, K. W., Zhang, F., Tam, S., Yung, P. S., & Chan, T. M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn216 · Cited by 79
IL-1β-Driven ST2L Expression Promotes Maturation Resistance in Rapamycin-Conditioned Dendritic Cells
Turnquist, H. R., Sumpter, T. L., Tsung, A., Zahorchak, A. F., Nakao, A., Nau, G. J., Liew, F. Y., Geller, D. A., & Thomson, A. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.62 · Cited by 78
Self-citationLehman, J. A., Calvo, V., & Gómez-Cambronero, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300376200 · Cited by 78
Characterization of the anti-inflammatory effect of FK-506 on human mast cells
de Paulis, A., Cirillo, R., Ciccarelli, A., de Crescenzo, G., Oriente, A., & Marone, G. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.12.4278 · Cited by 77
Uppaluri, R., Sheehan, K. C. F., Wang, L., Bui, J. D., Brotman, J. J., Lu, B., Gerard, C. J., Hancock, W. W., & Schreiber, R. D. (2008) · Transplantation · doi:10.1097/tp.0b013e31817b8e4b · Cited by 77
Th1 cell anergy and blockade in G1a phase of the cell cycle.
Gilbert, K. M., & Weigle, W. O. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1245 · Cited by 72
PSGL‐1 and mTOR regulate translation of ROCK‐1 and physiological functions of macrophages
Fox, R., Nhan, T. Q., Law, G. L., Morris, D., Liles, W. C., & Schwartz, S. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601522 · Cited by 66
Prevention of murine lupus disease in (NZB×NZW)F1 mice by sirolimus treatment
Ramos-Barron, M. A., Haces, C. P., Gómez-Alamillo, C., Santiuste-Torcida, I., Ruiz, J. C., Buelta-Carrillo, L., Merino, R., de Francisco, A. L. M., & Arias, M. (2007) · Lupus · doi:10.1177/0961203307081401 · Cited by 55
Current therapy for autoimmune hepatitis
Montaño‐Loza, A. J., & Czaja, A. J. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0768 · Cited by 50
The effect of rapamycin on T cell development in mice
Luo, H., Duguid, W. P., Chen, H., et al. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240331 · Cited by 49
Allen, A. N., Zheng, Y., Gardner, L. B., Safford, M., Horton, M. R., & Powell, J. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4797 · Cited by 47
Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice
Valle, A., Jofra, T., Stabilini, A., Atkinson, M. A., Roncarolo, M., & Battaglia, M. (2009) · Diabetes · doi:10.2337/db08-1432 · Cited by 46
Keever-Taylor, C. A., Browning, M. B., Johnson, B., Truitt, R. L., Bredeson, C., Behn, B., & Tsao, A. (2007) · Cytotherapy · doi:10.1080/14653240601145223 · Cited by 42
Involvement of a rapamycin-sensitive pathway in CD40-mediated activation of murine B cells in vitro
Sakata, A., Kuwahara, K., Ohmura, T., Inui, S., & Sakaguchi, N. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00053-x · Cited by 41
Das, S., Haddadi, A., Veniamin, S., & Samuel, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31557 · Cited by 37
Li, H.-L., Davis, W., & Puré, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9812 · Cited by 36
Imai, A., Sahara, H., Tamura, Y., Jimbow, K., Saito, T., Ezoe, K., Yotsuyanagi, T., & Sato, N. (2007) · European Journal of Immunology · doi:10.1002/eji.200636392 · Cited by 25
Carlson, R. P., Hartman, D. A., Ochalski, S. J., et al. (1998) · Inflammation Research · doi:10.1007/s000110050339 · Cited by 24
Macroautophagy in Immunity and Tolerance
Gannagé, M., & Münz, C. (2009) · Traffic : the International Journal of Intracellular Transport · doi:10.1111/j.1600-0854.2009.00883.x · Cited by 17
Faßbender, M., Herter, S., Holtappels, R., & Schild, H. (2008) · Medical Microbiology and Immunology · doi:10.1007/s00430-008-0091-4 · Cited by 10
Cited by
Human nutrition, the gut microbiome and the immune system
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011) · Nature · doi:10.1038/nature10213 · Cited by 2,588
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Targeting PI3K/Akt signal transduction for cancer therapy
He, Y., Sun, M. M., Zhang, G. G., Yang, J., Chen, K. S., Xu, W. W., & Li, B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00828-5 · Cited by 1,892
PI3K and cancer: lessons, challenges and opportunities
Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,709
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Liao, W., Lin, J.-X., & Leonard, W. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.01.004 · Cited by 1,075
Metadata
- Authors
- Thomson, A. W., Turnquist, H. R., & Raimondi, G.
- Venue
- Nature Reviews Immunology
- Published
- 2009-05
- Volume
- 9
- Issue
- 5
- Pages
- 324-337
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2090648684
- Cited by
- 847
- References
- 147
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.